Transcriptional	O
regulation	O
of	O
the	O
gene	O
encoding	O
the	O
human	B-protein
C-type	I-protein
lectin	I-protein
leukocyte	I-protein
receptor	I-protein
AIM/CD69	B-protein
and	O
functional	O
characterization	O
of	O
its	O
tumor	B-DNA
necrosis	I-DNA
factor-alpha-responsive	I-DNA
elements	I-DNA
.	O

The	O
human	B-protein
activation	I-protein
antigen	I-protein
CD69	B-protein
is	O
a	O
member	O
of	O
the	O
C-type	B-protein
animal	I-protein
lectin	I-protein
superfamily	I-protein
that	O
functions	O
as	O
a	O
signal-transmitting	B-protein
receptor	I-protein
.	O

Although	O
the	O
expression	O
of	O
CD69	B-protein
can	O
be	O
induced	O
in	O
vitro	O
on	O
cells	O
of	O
most	O
hematopoietic	O
lineages	O
with	O
a	O
wide	O
variety	O
of	O
stimuli	O
,	O
in	O
vivo	O
it	O
is	O
mainly	O
expressed	O
by	O
T-lymphocytes	B-cell_type
located	O
in	O
the	O
inflammatory	O
infiltrates	O
of	O
several	O
human	O
diseases	O
.	O

To	O
elucidate	O
the	O
mechanisms	O
that	O
regulate	O
the	O
constitutive	O
and	O
inducible	O
expression	O
of	O
CD69	B-protein
by	O
leukocytes	B-cell_type
,	O
we	O
isolated	O
the	O
promoter	B-DNA
region	I-DNA
of	O
the	O
CD69	B-protein
gene	O
and	O
carried	O
out	O
its	O
functional	O
characterization	O
.	O

Sequence	O
analysis	O
of	O
the	O
5'-flanking	B-DNA
region	I-DNA
of	O
the	O
CD69	B-DNA
gene	I-DNA
revealed	O
the	O
presence	O
of	O
a	O
potential	O
TATA	B-DNA
element	I-DNA
30	B-DNA
base	I-DNA
pairs	I-DNA
upstream	I-DNA
of	O
the	O
major	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
and	O
several	O
putative	O
binding	O
sequences	O
for	O
inducible	O
transcription	B-protein
factors	I-protein
(	O
NF-kappa	B-protein
B	I-protein
,	O
Egr-1	B-protein
,	O
AP-1	B-protein
)	O
,	O
which	O
might	O
mediate	O
the	O
inducible	O
expression	O
of	O
this	O
gene	O
.	O

Transient	O
expression	O
of	O
CD69	B-DNA
promoter-based	I-DNA
reporter	I-DNA
gene	I-DNA
constructs	I-DNA
in	O
K562	B-cell_line
cells	I-cell_line
indicated	O
that	O
the	O
proximal	B-DNA
promoter	I-DNA
region	I-DNA
spanning	O
positions	O
-78	O
to	O
+16	O
contained	O
the	O
cis-acting	B-DNA
sequences	I-DNA
necessary	O
for	O
basal	O
and	O
phorbol	O
12-myristate	O
13-acetate-inducible	O
transcription	O
of	O
the	O
CD69	B-DNA
gene	I-DNA
.	O

Removal	O
of	O
the	O
upstream	O
sequences	O
located	O
between	O
positions	O
-78	O
and	O
-38	O
resulted	O
in	O
decreased	O
promoter	O
strength	O
and	O
abolished	O
the	O
response	O
to	O
phorbol	O
12-myristate	O
13-acetate	O
.	O

We	O
also	O
found	O
that	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
is	O
capable	O
of	O
inducing	O
the	O
surface	O
expression	O
of	O
the	O
CD69	B-protein
molecule	O
as	O
well	O
as	O
the	O
promoter	O
activity	O
of	O
fusion	O
plasmids	O
that	O
contain	O
5'-flanking	O
sequences	O
of	O
the	O
CD69	B-protein
gene	O
,	O
suggesting	O
that	O
this	O
cytokine	O
may	O
regulate	O
in	O
vivo	O
the	O
expression	O
of	O
CD69	B-protein
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

37	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

21545-21551	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
Gene	NULL
Encoding	NULL
the	NULL
Human	NULL
C-type	NULL
Lectin	NULL
Leukocyte	NULL
Receptor	NULL
AIM/CD69	NULL
and	NULL
Functional	NULL
Characterization	NULL
of	NULL
Its	NULL
Tumor	NULL
Necrosis	NULL
Factor-a	NULL
«	NULL
-responsive	NULL
Elements*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
June	NULL
12	NULL
,	NULL
1995	NULL
)	NULL
Manuel	NULL
Lopez-Cabrerat	NULL
,	NULL
Eduardo	NULL
Munoz§	NULL
,	NULL
M.	NULL
Valle	NULL
Blazquez	NULL
$	NULL
§	NULL
,	NULL
Maria	NULL
A.	NULL
Ursa	NULL
,	NULL
Ana	NULL
G.	NULL
Santis	NULL
,	NULL
and	NULL
Francisco	NULL
Sanchez-Madrid1	NULL
From	NULL
the	NULL
Servicio	NULL
de	NULL
Inmunologia	NULL
and	NULL
the	NULL
{	NULL
Unidad	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
Hospital	NULL
de	NULL
la	NULL
Princesa	NULL
,	NULL
Universidad	NULL
Autonoma	NULL
de	NULL
Madrid	NULL
,	NULL
28006	NULL
Madrid	NULL
,	NULL
Spain	NULL
and	NULL
the	NULL
§Departamento	NULL
de	NULL
Fisiologia	NULL
e	NULL
Inmunologia	NULL
,	NULL
Facultad	NULL
de	NULL
Medicina	NULL
,	NULL
Universidad	NULL
de	NULL
Cordoba	NULL
,	NULL
Auda	NULL
Menéndez	NULL
Pidal	NULL
s/n	NULL
,	NULL
14004	NULL
Cordoba	NULL
,	NULL
Spain	NULL
The	NULL
human	NULL
activation	NULL
antigen	NULL
CD69	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C-type	NULL
animal	NULL
lectin	NULL
superfamily	NULL
that	NULL
functions	NULL
as	NULL
a	NULL
signal-transmitting	NULL
receptor	NULL
.	NULL

Although	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
vitro	NULL
on	NULL
cells	NULL
of	NULL
most	NULL
hema-topoietic	NULL
lineages	NULL
with	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
in	NULL
vivo	NULL
it	NULL
is	NULL
mainly	NULL
expressed	NULL
by	NULL
T-lymphocytes	NULL
located	NULL
in	NULL
the	NULL
inflammatory	NULL
infiltrates	NULL
of	NULL
several	NULL
human	NULL
diseases	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
CD69	NULL
by	NULL
leukocytes	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
and	NULL
carried	NULL
out	NULL
its	NULL
functional	NULL
characterization	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
potential	NULL
TATA	NULL
element	NULL
30	NULL
base	NULL
pairs	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
several	NULL
putative	NULL
binding	NULL
sequences	NULL
for	NULL
inducible	NULL
transcription	NULL
factors	NULL
(	NULL
NF-KB	NULL
,	NULL
Egr-1	NULL
,	NULL
AP-1	NULL
)	NULL
,	NULL
which	NULL
might	NULL
mediate	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
CD69	NULL
promoter-based	NULL
reporter	NULL
gene	NULL
constructs	NULL
in	NULL
K562	NULL
cells	NULL
indicated	NULL
that	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
spanning	NULL
positions	NULL
-78	NULL
to	NULL
+16	NULL
contained	NULL
the	NULL
cis-acting	NULL
sequences	NULL
necessary	NULL
for	NULL
basal	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate-inducible	NULL
transcription	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
upstream	NULL
sequences	NULL
located	NULL
between	NULL
positions	NULL
-78	NULL
and	NULL
-38	NULL
resulted	NULL
in	NULL
decreased	NULL
promoter	NULL
strength	NULL
and	NULL
abolished	NULL
the	NULL
response	NULL
to	NULL
phorbol	NULL
12-myristate	NULL
183-acetate	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
molecule	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
fusion	NULL
plasmids	NULL
that	NULL
contain	NULL
5'-flanking	NULL
sequences	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
cytokine	NULL
may	NULL
regulate	NULL
in	NULL
vivo	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cotransfection	NULL
experiments	NULL
demonstrated	NULL
that	NULL
the	NULL
CD69	NULL
gene	NULL
promoter	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
members	NULL
c-Rel	NULL
and	NULL
RelA	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
the	NULL
sequence	NULL
spanning	NULL
positions	NULL
-255	NULL
to	NULL
-170	NULL
abolished	NULL
both	NULL
the	NULL
response	NULL
to	NULL
TNF-a	NULL
«	NULL
and	NULL
the	NULL
transactivation	NULL
by	NULL
These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
NF-xB-binding	NULL
site	NULL
located	NULL
at	NULL
position	NULL
-223	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
TNF-a-induced	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

Mobil	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
PB92-0318	NULL
(	NULL
to	NULL
F.	NULL
S-M.	NULL
)	NULL
,	NULL
Grant	NULL
FIS	NULL
95/0208	NULL
(	NULL
to	NULL
M.	NULL
L.-C.	NULL
)	NULL
,	NULL
and	NULL
Grant	NULL
SAF	NULL
95/0474	NULL
(	NULL
to	NULL
E.	NULL
M.	NULL
)	NULL
from	NULL
the	NULL
Ministries	NULL
of	NULL
Education	NULL
and	NULL
Health	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
Gen	NULL
Bank	NULL
``	NULL
``	NULL
/EMBL	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
Z38109	NULL
.	NULL

[	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Servicio	NULL
de	NULL
Inmunologia	NULL
,	NULL
Hospital	NULL
de	NULL
la	NULL
Princesa	NULL
,	NULL
Diego	NULL
de	NULL
Leon	NULL
,	NULL
E-28006	NULL
Madrid	NULL
,	NULL
Spain	NULL
.	NULL

Fax	NULL
:	NULL
34-1-309-24-96.	NULL
ity	NULL
shift	NULL
assays	NULL
showed	NULL
that	NULL
the	NULL
two	NULL
NF-kB	NULL
motifs	NULL
located	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
(	NULL
positions	NULL
-223	NULL
and	NULL
-160	NULL
)	NULL
bind	NULL
various	NULL
NF-	NULL
«	NULL
B-related	NULL
complexes	NULL
,	NULL
including	NULL
the	NULL
heterodimers	NULL
p50/ReIA	NULL
and	NULL
p50/c-Rel	NULL
and	NULL
homodimers	NULL
of	NULL
p50	NULL
(	NULL
KBF-1	NULL
)	NULL
and	NULL
RelA	NULL
.	NULL

Our	NULL
findings	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
regulated	NULL
synthesis	NULL
of	NULL
CD69	NULL
in	NULL
vivo	NULL
and	NULL
suggest	NULL
that	NULL
TNF-a	NULL
has	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
molecule	NULL
at	NULL
sites	NULL
of	NULL
chronic	NULL
inflammation	NULL
.	NULL

The	NULL
human	NULL
activation	NULL
inducer	NULL
molecule	NULL
(	NULL
AIM/CD69	NULL
)	NULL
is	NULL
a	NULL
phosphorylated	NULL
disulfide-linked	NULL
27/33-kDa	NULL
transmembrane	NULL
ho-modimeric	NULL
glycoprotein	NULL
(	NULL
Sanchez-Mateos	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
CD69	NULL
molecule	NULL
is	NULL
rapidly	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
T-lymphocytes	NULL
upon	NULL
in	NULL
vitro	NULL
activation	NULL
with	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
agents	NULL
,	NULL
including	NULL
anti-CD3/T	NULL
cell	NULL
receptor	NULL
and	NULL
anti-CD2	NULL
mAbs	NULL
,	NULL
``	NULL
activators	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
phytohemagglutinin	NULL
(	NULL
Cebrian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Hara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
is	NULL
inducible	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
NK	NULL
cells	NULL
,	NULL
B-lympho-cytes	NULL
,	NULL
and	NULL
eosinophils	NULL
(	NULL
Hartnell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Lanier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD69	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
vivo	NULL
on	NULL
platelets	NULL
and	NULL
on	NULL
a	NULL
small	NULL
percentage	NULL
of	NULL
resident	NULL
T-	NULL
and	NULL
B-cells	NULL
of	NULL
different	NULL
lymphoid	NULL
tissues	NULL
(	NULL
Sanchez-Mateos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Testi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
physiologic	NULL
ligand	NULL
for	NULL
CD69	NULL
has	NULL
not	NULL
been	NULL
identified	NULL
so	NULL
far	NULL
,	NULL
experiments	NULL
with	NULL
specific	NULL
mAbs	NULL
indicate	NULL
that	NULL
this	NULL
antigen	NULL
functions	NULL
as	NULL
a	NULL
signal-transmitting	NULL
receptor	NULL
.	NULL

Signals	NULL
triggered	NULL
by	NULL
CD69	NULL
mAbs	NULL
in	NULL
T-lymphocytes	NULL
include	NULL
increase	NULL
in	NULL
intracellular	NULL
calcium	NULL
concentration	NULL
and	NULL
result	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
different	NULL
cytokines	NULL
and	NULL
their	NULL
receptors	NULL
,	NULL
enhancement	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
c-myc	NULL
and	NULL
c-fos	NULL
protooncogenes	NULL
,	NULL
and	NULL
cell	NULL
proliferation	NULL
(	NULL
Cebrian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Nakamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Santis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Testi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Tugores	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
NK	NULL
cells	NULL
and	NULL
platelets	NULL
,	NULL
CD69	NULL
also	NULL
acts	NULL
as	NULL
a	NULL
triggering	NULL
mol-ecule	NULL
,	NULL
being	NULL
involved	NULL
in	NULL
the	NULL
redirected	NULL
target	NULL
cell	NULL
lysis	NULL
by	NULL
in-terleukin-2-activated	NULL
NK	NULL
cells	NULL
(	NULL
Moretta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
platelet	NULL
aggregation	NULL
,	NULL
Ca**	NULL
influx	NULL
,	NULL
and	NULL
hydrolysis	NULL
of	NULL
arachidonic	NULL
acid	NULL
(	NULL
Testi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
cloning	NULL
of	NULL
cDNAs	NULL
encoding	NULL
human	NULL
and	NULL
mouse	NULL
CD69	NULL
revealed	NULL
that	NULL
this	NULL
antigen	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ca**-dependent	NULL
(	NULL
C-type	NULL
)	NULL
animal	NULL
lectin	NULL
superfamily	NULL
of	NULL
type	NULL
II	NULL
transmembrane	NULL
receptors	NULL
(	NULL
Hamann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Lépez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Ziegler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
superfamily	NULL
includes	NULL
the	NULL
human	NULL
NKG2	NULL
,	NULL
rat	NULL
and	NULL
mouse	NULL
NKR-P1	NULL
,	NULL
and	NULL
mouse	NULL
Ly-49	NULL
families	NULL
of	NULL
NK	NULL
cell-specific	NULL
antigens	NULL
as	NULL
well	NULL
as	NULL
the	NULL
low	NULL
avidity	NULL
IgE	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
mAbs	NULL
,	NULL
monoclonal	NULL
antibodies	NULL
;	NULL
NK	NULL
,	NULL
natural	NULL
killer	NULL
;	NULL
TNF-	NULL
@	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kbp	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
.	NULL

21545	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21546	NULL
receptor	NULL
(	NULL
CD23	NULL
)	NULL
,	NULL
the	NULL
Kupffer	NULL
cell	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
hepatic	NULL
asialoglycoprotein	NULL
receptor	NULL
(	NULL
Drickamer	NULL
,	NULL
1993	NULL
;	NULL
Yokoyama	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
of	NULL
genes	NULL
encoding	NULL
human	NULL
and	NULL
mouse	NULL
CD69	NULL
further	NULL
evidenced	NULL
that	NULL
CD69	NULL
is	NULL
evolu-tionarily	NULL
related	NULL
to	NULL
these	NULL
C-type	NULL
lectin	NULL
receptors	NULL
(	NULL
Santis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Ziegler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
CD69	NULL
gene	NULL
is	NULL
clustered	NULL
with	NULL
other	NULL
C-type	NULL
lectin-encoding	NULL
genes	NULL
within	NULL
a	NULL
genetic	NULL
region	NULL
named	NULL
the	NULL
NK	NULL
cell	NULL
complex	NULL
(	NULL
Drickamer	NULL
,	NULL
1993	NULL
;	NULL
Lopez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Yokoyama	NULL
,	NULL
1993	NULL
;	NULL
Ziegler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
CD69	NULL
antigen	NULL
is	NULL
undetectable	NULL
on	NULL
peripheral	NULL
blood	NULL
lym-phocytes	NULL
;	NULL
however	NULL
,	NULL
it	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
by	NULL
the	NULL
majority	NULL
of	NULL
T-cells	NULL
in	NULL
the	NULL
inflammatory	NULL
cell	NULL
infiltrates	NULL
of	NULL
several	NULL
human	NULL
diseases	NULL
such	NULL
as	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
chronic	NULL
viral	NULL
hepatitis	NULL
(	NULL
Garcia-Monzon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Laffon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
inflammatory	NULL
cytokines	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
CD69	NULL
expression	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
TNF-a	NULL
is	NULL
produced	NULL
by	NULL
human	NULL
hepatocytes	NULL
in	NULL
chronic	NULL
viral	NULL
hepatitis	NULL
(	NULL
Gonzglez-Amaro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TNF-a	NULL
and	NULL
other	NULL
cytokines	NULL
may	NULL
play	NULL
a	NULL
key	NULL
regulatory	NULL
role	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
in	NULL
vivo	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
that	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
molecule	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
Hamann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
Lépez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Ziegler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
pattern	NULL
of	NULL
CD69	NULL
expression	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
the	NULL
5'-region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
and	NULL
analyzed	NULL
its	NULL
inducible	NULL
promoter	NULL
activity	NULL
.	NULL

We	NULL
describe	NULL
herein	NULL
that	NULL
the	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
functions	NULL
as	NULL
a	NULL
PMA-inducible	NULL
promoter	NULL
element	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
report	NULL
that	NULL
TNF-a	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
both	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
and	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
5'-region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
within	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
may	NULL
account	NULL
for	NULL
the	NULL
TNF-w-inducible	NULL
promoter	NULL
activity	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Isolation	NULL
of	NULL
Genomic	NULL
Clones	NULL
Containing	NULL
the	NULL
5'-Region	NULL
of	NULL
the	NULL
CD69	NULL
Gene-A	NULL
total	NULL
of	NULL
5	NULL
X	NULL
10	NULL
``	NULL
clones	NULL
from	NULL
an	NULL
EcoRI-digested	NULL
human	NULL
chromosome	NULL
12-specific	NULL
library	NULL
in	NULL
Charon	NULL
21A	NULL
(	NULL
ATCC	NULL
57727	NULL
)	NULL
were	NULL
screened	NULL
as	NULL
described	NULL
(	NULL
Santis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
using	NULL
a	NULL
456-bp	NULL
``	NULL
°P-labeled	NULL
probe	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
CD69	NULL
cDNA	NULL
(	NULL
nucleotides	NULL
12-467	NULL
)	NULL
(	NULL
Lépez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

After	NULL
four	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
three	NULL
positive	NULL
clones	NULL
were	NULL
isolated	NULL
.	NULL

These	NULL
clones	NULL
were	NULL
then	NULL
hybridized	NULL
with	NULL
*°P-labeled	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
5'-untranslated	NULL
(	NULL
nucleotides	NULL
12-31	NULL
)	NULL
and	NULL
transmembrane-encoding	NULL
(	NULL
nucleotides	NULL
209-228	NULL
)	NULL
sequences	NULL
of	NULL
the	NULL
CD69	NULL
cDNA	NULL
(	NULL
Lépez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Since	NULL
these	NULL
clones	NULL
hybridized	NULL
only	NULL
with	NULL
the	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
5'-untranslated	NULL
sequence	NULL
,	NULL
they	NULL
contained	NULL
DNA	NULL
inserts	NULL
corresponding	NULL
to	NULL
the	NULL
5'-portion	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

Restriction	NULL
analysis	NULL
of	NULL
the	NULL
clones	NULL
indicated	NULL
that	NULL
they	NULL
possessed	NULL
the	NULL
same	NULL
3-kbp	NULL
EcoRI	NULL
insert	NULL
,	NULL
which	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pBluescript	NULL
plasmid	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

DNA	NULL
sequencing	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
dideoxy	NULL
termination	NULL
method	NULL
either	NULL
by	NULL
subcloning	NULL
restriction	NULL
fragments	NULL
into	NULL
pBluescript	NULL
vectors	NULL
or	NULL
by	NULL
direct	NULL
oligonucleotide-primed	NULL
DNA	NULL
sequencing	NULL
with	NULL
internal	NULL
primers	NULL
.	NULL

Plasmid	NULL
Constructions	NULL
,	NULL
Transfections	NULL
,	NULL
and	NULL
Luciferase	NULL
Assays-Re-striction	NULL
endonuclease	NULL
site	NULL
mapping	NULL
and	NULL
partial	NULL
DNA	NULL
sequencing	NULL
of	NULL
the	NULL
cloned	NULL
3-kbp	NULL
insert	NULL
revealed	NULL
that	NULL
it	NULL
contained	NULL
the	NULL
first	NULL
exon	NULL
,	NULL
a	NULL
part	NULL
of	NULL
the	NULL
first	NULL
intron	NULL
,	NULL
and	NULL
a	NULL
2.1-kbp	NULL
fragment	NULL
containing	NULL
the	NULL
putative	NULL
upstream	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

Five	NULL
restriction	NULL
fragments	NULL
of	NULL
the	NULL
latter	NULL
region	NULL
(	NULL
EeoRI-Sacl	NULL
,	NULL
Pvull-Sacl	NULL
,	NULL
HindIII-Sacl	NULL
,	NULL
Bg/ilI-Sacl	NULL
,	NULL
and	NULL
Xbal-Sacl	NULL
of	NULL
2.1	NULL
,	NULL
1.4	NULL
,	NULL
0.64	NULL
,	NULL
0.49	NULL
,	NULL
and	NULL
0.27	NULL
kbp	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
in	NULL
the	NULL
pXFP2	NULL
plasmid	NULL
(	NULL
Nordeen	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Three	NULL
additional	NULL
deletion	NULL
fragments	NULL
of	NULL
186	NULL
,	NULL
94	NULL
,	NULL
and	NULL
54	NULL
bp	NULL
were	NULL
generated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
same	NULL
reporter	NULL
plasmid	NULL
.	NULL

K562	NULL
erythroleukemic	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
each	NULL
recombinant	NULL
plasmid	NULL
using	NULL
10	NULL
pg	NULL
of	NULL
Lipofectin	NULL
reagent	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
,	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

To	NULL
normalize	NULL
transfection	NULL
efficiency	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pCMVBG-gal	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
ligated	NULL
to	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
,	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

After	NULL
48	NULL
h	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
of	NULL
transfection	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
cell	NULL
extracts	NULL
containing	NULL
identical	NULL
B-galactosidase	NULL
activity	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
luciferase	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Light	NULL
emission	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
Lumat	NULL
LB9501	NULL
luminometer	NULL
(	NULL
Berthold	NULL
,	NULL
Wildbad	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
and	NULL
TNF-a	NULL
on	NULL
the	NULL
CD69	NULL
promoter	NULL
activity	NULL
,	NULL
half	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
12-16	NULL
h	NULL
with	NULL
either	NULL
20	NULL
ng/ml	NULL
PMA	NULL
or	NULL
50	NULL
ng/ml	NULL
human	NULL
recombinant	NULL
TNF	NULL
-	NULL
«	NULL
(	NULL
8.2	NULL
X	NULL
10	NULL
``	NULL
units/mg	NULL
;	NULL
Wichem	NULL
,	NULL
Vienna	NULL
)	NULL
.	NULL

As	NULL
positive	NULL
controls	NULL
for	NULL
PMA	NULL
and	NULL
TNF	NULL
-	NULL
«	NULL
stimulation	NULL
,	NULL
we	NULL
used	NULL
the	NULL
plasmids	NULL
pGL2P	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
luciferase	NULL
gene	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
,	NULL
and	NULL
pKBF-Luc	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
A.	NULL
Israél	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
of	NULL
the	NULL
H-2K	NULL
``	NULL
gene	NULL
(	NULL
Yano	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
gene	NULL
promoter	NULL
.	NULL

To	NULL
obtain	NULL
K562	NULL
stable	NULL
transfectants	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
pAIM1.4-Lue	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
pSV2-neo	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Nueda	NULL
et	NULL
a.	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
selected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G418	NULL
(	NULL
1	NULL
mg/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
by	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
family	NULL
members	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
cotransfected	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
Lipofectin	NULL
,	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
CD69	NULL
promoter-derived	NULL
plasmids	NULL
and	NULL
5-10	NULL
pug	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
pRe/CMV-p50	NULL
,	NULL
pRe/CMV-c-Rel	NULL
,	NULL
or	NULL
pRe/CMV-RelA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Israél	NULL
)	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
each	NULL
protein	NULL
,	NULL
into	NULL
the	NULL
pRe/CMV	NULL
plasmid	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
Le	NULL
Bail	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Fluorescence-activated	NULL
Cell	NULL
Sorting	NULL
Analysis-K562	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
either	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
TNF-a	NULL
(	NULL
50	NULL
ng/m1	NULL
)	NULL
,	NULL
and	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
mAb	NULL
TP1/55	NULL
(	NULL
Cebrign	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
S	NULL
&	NULL
nchez-Mateos	NULL
and	NULL
Madrid	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
hybridoma	NULL
culture	NULL
supernatant	NULL
,	NULL
followed	NULL
by	NULL
washing	NULL
and	NULL
labeling	NULL
with	NULL
a	NULL
fluores-cein	NULL
isothiocyanate-tagged	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Cell-surface	NULL
fluorescence	NULL
was	NULL
analyzed	NULL
using	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton-Dickinson	NULL
&	NULL
Co.	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-COS-7	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
procedure	NULL
with	NULL
the	NULL
expression	NULL
vectors	NULL
pRe/CMV-p50	NULL
(	NULL
0.5	NULL
pg/ml	NULL
)	NULL
and	NULL
pRe/	NULL
CMV-RelA	NULL
(	NULL
1.0	NULL
ug/ml	NULL
)	NULL
.	NULL

Small-scale	NULL
nuclear	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
and	NULL
untransfected	NULL
K562	NULL
cells	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
a	NULL
procedure	NULL
described	NULL
elsewhere	NULL
(	NULL
Schreiber	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
K562	NULL
cells	NULL
were	NULL
obtained	NULL
after	NULL
a	NULL
6-h	NULL
treatment	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
human	NULL
recombinant	NULL
TNF-a	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
for	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
at	NULL
0	NULL
°C	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
containing	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
KCl	NULL
6	NULL
my	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
0.5	NULL
ng	NULL
of	NULL
3'-end	NULL
labeled	NULL
probe	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

After	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
the	NULL
mixtures	NULL
were	NULL
electrophoretically	NULL
separated	NULL
on	NULL
4-5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
0.5	NULL
ul	NULL
of	NULL
rabbit	NULL
anti-p50	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
anti-RelA	NULL
,	NULL
anti-c-Rel	NULL
,	NULL
or	NULL
anti-p52	NULL
specific	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
corresponding	NULL
binding	NULL
reaction	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

These	NULL
antisera	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

A.	NULL
Israél	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

For	NULL
competition	NULL
,	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
and	NULL
their	NULL
complementaries	NULL
)	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
CD69-	NULL
«	NULL
B-1	NULL
,	NULL
5'-GATCAGACAA-CAGGGAAAACCCATACTTC-3	NULL
'	NULL
(	NULL
nucleotides	NULL
-170	NULL
to	NULL
-144	NULL
)	NULL
,	NULL
and	NULL
CD69-kB-2	NULL
,	NULL
5	NULL
-GATCAGAGTCTGGGAAAATCCCACTTTCC-3	NULL
'	NULL
(	NULL
nucleotides	NULL
-232	NULL
to	NULL
-206	NULL
)	NULL
.	NULL

The	NULL
synthetic	NULL
oligonucleotides	NULL
used	NULL
for	NULL
competition	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
VP9	NULL
,	NULL
CCTCCG-3	NULL
'	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
M.	NULL
Redondo	NULL
,	NULL
Hospital	NULL
de	NULL
la	NULL
Princesa	NULL
,	NULL
Madrid	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
from	NULL
the	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
promoter	NULL
;	NULL
KBF	NULL
,	NULL
5'-AGCTTGGGGATTCCCCAT-3	NULL
'	NULL
,	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
H-2K	NULL
``	NULL
gene	NULL
(	NULL
Yano	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
;	NULL
AP-1	NULL
,	NULL
5-CGCTTGATGAGTCAGCCGGAA-3	NULL
'	NULL
;	NULL
and	NULL
OCT-1	NULL
,	NULL
5'-TGTCGAATGCAAATCACTAGA-3	NULL
'	NULL
.	NULL

RESULTS	NULL
Structure	NULL
of	NULL
the	NULL
5'-Region	NULL
of	NULL
the	NULL
CD69	NULL
Gene-The	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
CD69	NULL
antigen	NULL
has	NULL
previously	NULL
been	NULL
mapped	NULL
to	NULL
chromosome	NULL
12p13-p12	NULL
(	NULL
Lopez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

To	NULL
isolate	NULL
the	NULL
5'-regulatory	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
,	NULL
an	NULL
EcoRI-digested	NULL
chromosome	NULL
12-specific	NULL
library	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
456-bp	NULL
specific	NULL
probe	NULL
that	NULL
contained	NULL
the	NULL
5'-end	NULL
of	NULL
CD69-encoding	NULL
cDNA	NULL
.	NULL

Three	NULL
positive	NULL
clones	NULL
containing	NULL
the	NULL
same	NULL
3-kbp	NULL
insert	NULL
were	NULL
obtained	NULL
.	NULL

Restriction	NULL
mapping	NULL
analysis	NULL
and	NULL
hybrid	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
ization	NULL
experiments	NULL
with	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
5'-untranslated	NULL
and	NULL
transmembrane-encoding	NULL
sequences	NULL
of	NULL
the	NULL
CD69	NULL
cDNA	NULL
indicated	NULL
that	NULL
the	NULL
cloned	NULL
DNA	NULL
fragment	NULL
contained	NULL
the	NULL
5'-portion	NULL
of	NULL
CD69	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Partial	NULL
sequencing	NULL
of	NULL
the	NULL
A	NULL
I	NULL
--	NULL
--	NULL
-5~REGION	NULL
--	NULL
-	NULL
3000	NULL
2000	NULL
1000	NULL
0	NULL
(	NULL
bp	NULL
)	NULL
I	NULL
I	NULL
|	NULL
|	NULL
1	NULL
|	NULL
Po	NULL
X	NULL
HOB	NULL
X	NULL
S	NULL
S	NULL
BB	NULL
E	NULL
L	NULL
___	NULL
|	NULL
E	NULL
Charon	NULL
21A	NULL
<	NULL
--	NULL
-	NULL
|	NULL
Charon	NULL
21A	NULL
luke	NULL
[	NULL
--	NULL
--	NULL
_________	NULL
L___________	NULL
+1	NULL
B	NULL
Xba~I	NULL
~1050	NULL
TCTAGATCATAACTTCCAACCCACCTATCCATAAAATTTAACGTCTTTATTCTAAATAACTCATATTAAT	NULL
-980	NULL
AATAAAMTTTGGGGCACCAACATTATTAMNTCAGAGTGGTATTTTGATTTCCCTCCTTAAATCACCATAC®	NULL
-910	NULL
TAGCTTTCTGCATTCATCTTCCGTTSACTOTCATTACTTGTCTICAGTGACACTGATACCACACCGATETT	NULL
-840	NULL
TTAAATAATAMTCATACCTCAAAACACTGAAGTCTCACAGCTATCTGAACAGAXTAACCTAGCAGCACAGG	NULL
-770	NULL
GGCAGAATIGAMCGCAGCTGTTACIGAGCTGACATAAAAGCAGTCTAAATGACAGTAAAATGTIGACAAGAA	NULL
~700	NULL
AATTAGqAGGAAACAAATGAAACAGATAATTTAAGATAAACAATTTTAGAGCATAGCAAGGAAGTTCCAG	NULL
~630	NULL
ACCAC§	NULL
;	NULL
22	NULL
;	NULL
;	NULL
;	NULL
ZTGTTTCCTGCATTCTTACTTCTTACTACGTGATACATCTAGTCACCAGGGAAGAAGC	NULL
-560	NULL
GAMTGACACACTTCCAAAAACCAATTCGTAGCTTTCTAAATARAACCCTTTCTAGCTGGACAGAGATCCA	NULL
~490	NULL
TGAGCATAG:2§	NULL
;	NULL
£	NULL
;	NULL
TAAAATTCATGTTCAGCAATAAATCCTGGGGCCCCAGACAGTGTCAGGTGCATAG	NULL
kB-3	NULL
-420	NULL
~350	NULL
TCTCCTICTCCAAATTATCTTCATCTCAAAGACAGGAACCTCTAACTTITAATTCTTTACTTAGATTATG	NULL
kB-2	NULL
Kba-I	NULL
-280	NULL
CTeTCTeCTAAACTGTTTATGTTTTCTAGAAATTTAAGGCAGGATGTCTCAGAGTC	NULL
kB	NULL
gac	NULL
-210	NULL
TPPCCTCCTIGCTACACCTTACAGTTGTCAGAAAGCACATTTCACACAACAGG	NULL
ATACTTCACC	NULL
-140	NULL
ACAACAACACACTATACATTGTCTGGTCCACIGCAGCATAAXTTAAAGAGAAACAATCTAGTCAAGCAAG	NULL
Gc-rich	NULL
T	NULL
SAGACATCATCAGGGAGTATAAACTCTGAGATGCCTCAGAGCCTCAC	NULL
-70	NULL
TAGGCGGCAAGAGG	NULL
+1	NULL
AGACTCAACAAGAGCTCCAGCAAAGACTTTCACTGTAGCTTCACTTGACCTGAGATTAACTAGGGANTCT	NULL
+71	NULL
TGAGANTAAACRATGACCTCTCAAAATTCTTTCCTAGCACACAACAGCTCTTTGCATCCGCAGAGTGGACA	NULL
I	NULL
B	NULL
N	NULL
C	NULL
OF	NULL
V	NULL
A	NULL
66k	NULL
}	NULL
«	NULL
66k	NULL
660	NULL
+141	NULL
AGAAAgtaagtcagatctgattgectatttactotctggtatctctatatatgacattaatagtagttat	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
5'-region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
restriction	NULL
map	NULL
of	NULL
the	NULL
cloned	NULL
fragment	NULL
encompassing	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

The	NULL
restriction	NULL
sites	NULL
are	NULL
Bg/lI	NULL
(	NULL
B	NULL
)	NULL
,	NULL
EcoRI	NULL
(	NULL
E	NULL
)	NULL
,	NULL
HindIII	NULL
(	NULL
H	NULL
)	NULL
,	NULL
Poull	NULL
(	NULL
P	NULL
)	NULL
,	NULL
Sacl	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
Xbal	NULL
(	NULL
X	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
filled	NULL
box	NULL
.	NULL

B	NULL
,	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
5'-regulatory	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

First	NULL
exon	NULL
nucleotides	NULL
are	NULL
underlined	NULL
,	NULL
and	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
denoted	NULL
by	NULL
+1	NULL
.	NULL

The	NULL
first	NULL
intron	NULL
sequence	NULL
appears	NULL
in	NULL
lower-case	NULL
lefters	NULL
.	NULL

Shaded	NULL
areas	NULL
correspond	NULL
to	NULL
consensus	NULL
binding	NULL
sequences	NULL
for	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
TATA	NULL
box	NULL
is	NULL
indicated	NULL
by	NULL
double	NULL
underlining	NULL
.	NULL

Prediction	NULL
of	NULL
putative	NULL
transcription	NULL
factor-binding	NULL
sites	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
the	NULL
C-coded	NULL
program	NULL
SITIOS	NULL
(	NULL
Dr.	NULL
M.	NULL
A.	NULL
Vega	NULL
,	NULL
Instituto	NULL
Lépez	NULL
Neyra	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investiga-ciones	NULL
Cientfficas	NULL
)	NULL
,	NULL
which	NULL
includes	NULL
Release	NULL
5.0	NULL
of	NULL
D.	NULL
Ghosh	NULL
's	NULL
transcription	NULL
factor	NULL
data	NULL
base	NULL
(	NULL
Ghosh	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

21547	NULL
genomic	NULL
DNA	NULL
insert	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
exon	NULL
that	NULL
includes	NULL
the	NULL
whole	NULL
reported	NULL
5'-untranslated	NULL
region	NULL
and	NULL
that	NULL
codes	NULL
for	NULL
the	NULL
first	NULL
21	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
DNA	NULL
cloned	NULL
was	NULL
interrupted	NULL
by	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
,	NULL
a	NULL
2.1-kbp	NULL
fragment	NULL
containing	NULL
the	NULL
putative	NULL
CD69	NULL
gene	NULL
promoter	NULL
region	NULL
was	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
has	NULL
been	NULL
located	NULL
81	NULL
nucleotides	NULL
upstream	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
codon	NULL
(	NULL
Santis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
analysis	NULL
1050	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
CAP	NULL
site	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
canonical	NULL
TATA	NULL
box	NULL
at	NULL
position	NULL
-30	NULL
and	NULL
a	NULL
GC-rich	NULL
sequence	NULL
at	NULL
position	NULL
-52	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
three	NULL
potential	NULL
NF-	NULL
«	NULL
B/Rel-binding	NULL
sequences	NULL
were	NULL
identified	NULL
at	NULL
positions	NULL
-160	NULL
,	NULL
-223	NULL
,	NULL
and	NULL
-373	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
two	NULL
proximal	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
(	NULL
kB-1	NULL
and	NULL
kB-2	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
found	NULL
in	NULL
the	NULL
gene	NULL
promoters	NULL
of	NULL
e-mye	NULL
and	NULL
interleukin-6	NULL
,	NULL
respectively	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
most	NULL
upstream	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
kB-3	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
(	NULL
H-2K	NULL
``	NULL
)	NULL
gene	NULL
promoter	NULL
(	NULL
Yano	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Functional	NULL
Analysis	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
Promoter-To	NULL
functionally	NULL
characterize	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
,	NULL
eight	NULL
genomic	NULL
fragments	NULL
containing	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
were	NULL
ligated	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
and	NULL
their	NULL
basal	NULL
and	NULL
PMA-inducible	NULL
promoter	NULL
activities	NULL
were	NULL
assessed	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
CD69	NULL
in	NULL
an	NULL
inducible	NULL
manner	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
relative	NULL
promoter	NULL
activities	NULL
of	NULL
the	NULL
different	NULL
constructs	NULL
indicated	NULL
that	NULL
the	NULL
progressive	NULL
removal	NULL
of	NULL
5'-sequences	NULL
up	NULL
to	NULL
position	NULL
-78	NULL
did	NULL
not	NULL
affect	NULL
significantly	NULL
the	NULL
uninduced	NULL
promoter	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
94-bp	NULL
fragment	NULL
,	NULL
spanning	NULL
positions	NULL
-78	NULL
to	NULL
+16	NULL
,	NULL
contained	NULL
the	NULL
cis-acting	NULL
elements	NULL
necessary	NULL
for	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
constructs	NULL
up	NULL
to	NULL
position	NULL
-78	NULL
resulted	NULL
in	NULL
augmented	NULL
promoter	NULL
activities	NULL
,	NULL
with	NULL
inductions	NULL
that	NULL
ranged	NULL
from	NULL
15	NULL
to	NULL
125-fold	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
upstream	NULL
sequences	NULL
up	NULL
to	NULL
position	NULL
-38	NULL
resulted	NULL
in	NULL
decreased	NULL
promoter	NULL
strength	NULL
and	NULL
abolishment	NULL
of	NULL
the	NULL
response	NULL
to	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
PMA	NULL
up-regulates	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
in	NULL
hemopoietic	NULL
cells	NULL
,	NULL
a	NULL
phenomenon	NULL
that	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
described	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
molecule	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
sequence	NULL
located	NULL
between	NULL
positions	NULL
-78	NULL
and	NULL
-38	NULL
contained	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
cis-acting	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
PMA-inducible	NULL
promoter	NULL
activity	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
41-bp	NULL
fragment	NULL
possesses	NULL
a	NULL
GC-rich	NULL
sequence	NULL
e	NULL
--	NULL
500bp	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
E	NULL
p	NULL
x	NULL
HOB	NULL
X	NULL
S	NULL
S	NULL
BB	NULL
OE	NULL
LUCIFERASE	NULL
ACTIVITY	NULL
CD69	NULL
promoter	NULL
.	NULL

The	NULL
schematic	NULL
repre-	NULL
[	NULL
|	NULL
|	NULL
1	NULL
1	NULL
I	NULL
i	NULL
(	NULL
__|	NULL
|	NULL
(	NULL
Light	NULL
Units	NULL
X1000	NULL
)	NULL
sentation	NULL
of	NULL
the	NULL
CD69	NULL
promoter-based	NULL
re-	NULL
U	NULL
al	NULL
porter	NULL
gene	NULL
constructs	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
+1	NULL
-PMA	NULL
+P	NULL
MA	NULL
INDUCT	NULL
.	NULL

left	NULL
,	NULL
and	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
is	NULL
represented	NULL
at	NULL
the	NULL
top	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
and	NULL
the	NULL
first	NULL
intron	NULL
__	NULL
PAIM2.1-LUC	NULL
_	NULL
i-	NULL
28.1	NULL
1745.2	NULL
62	NULL
are	NULL
indicated	NULL
by	NULL
filled	NULL
and	NULL
hatched	NULL
boxes	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
nomenclature	NULL
of	NULL
the	NULL
de-	NULL
__	NULL
pAIM1.4-LUC	NULL
29.3	NULL
3656.5	NULL
125	NULL
letion	NULL
plasmids	NULL
is	NULL
based	NULL
on	NULL
the	NULL
most	NULL
5'-nucleotide	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
sequence	NULL
_	NULL
pAIMG624-LUC	NULL
39.6	NULL
4051.2	NULL
102	NULL
present	NULL
,	NULL
and	NULL
its	NULL
position	NULL
is	NULL
denoted	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
_	NULL
pAIM480-LUC	NULL
27.6	NULL
1471.7	NULL
53	NULL
(	NULL
position	NULL
+1	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
and	NULL
PMA-induced	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
5'-region	NULL
of	NULL
__	NULL
pAIM255-LUC	NULL
40.9	NULL
1273.6	NULL
31	NULL
the	NULL
CD69	NULL
gene	NULL
was	NULL
determined	NULL
by	NULL
transient	NULL
expression	NULL
of	NULL
luciferase	NULL
gene-based	NULL
__	NULL
pAIM170-LUC	NULL
30.4	NULL
493.6	NULL
16	NULL
constructs	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
least	NULL
four	NULL
times	NULL
,	NULL
pAIM7	NULL
8-LUC	NULL
31.7	NULL
470.8	NULL
15	NULL
and	NULL
the	NULL
data	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

INDUCT	NULL
.	NULL

,	NULL
pAIM38-LUC	NULL
2.9	NULL
3.7	NULL
1.3	NULL
induction	NULL
.	NULL

pxP2	NULL
0.4	NULL
1.1	NULL
2.7	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21548	NULL
A	NULL
B	NULL
aso-	NULL
©	NULL
300-MEDIUM	NULL
x63	NULL
2	NULL
(	NULL
ae	NULL
i	NULL
;	NULL
an	NULL
;	NULL
aso-lar	NULL
5	NULL
5	NULL
G	NULL
a	NULL
<	NULL
§	NULL
i	NULL
5	NULL
E3	NULL
C	NULL
``	NULL
200-|	NULL
D	NULL
&	NULL
€	NULL
e	NULL
2	NULL
S	NULL
'	NULL
100-3	NULL
<	NULL
_	NULL
_	NULL
50-I	NULL
Lt	NULL
©	NULL
TRANSFECTANT	NULL
:	NULL
FLUORESCENCE	NULL
-	NULL
INTENSITY	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
C	NULL
®	NULL
[	NULL
___	NULL
]	NULL
|___	NULL
n	NULL
LUCIFERASE	NULL
ACTIVITY	NULL
{	NULL
roup	NULL
Activation	NULL
)	NULL
pRC/CMY-250	NULL
-	NULL
s	NULL
010	NULL
-o-	NULL
_o	NULL
~	NULL
pRC/CMY-ReIA	NULL
.	NULL

-	NULL
-	NULL
~	NULL
s	NULL
10	NULL
20	NULL
_	NULL
pRC/CMV-c-Rel	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
10	NULL
«	NULL
a	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

TNF-a	NULL
«	NULL
-induced	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
CD69	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
on	NULL
unstimulated	NULL
K562	NULL
cells	NULL
and	NULL
on	NULL
K562	NULL
cells	NULL
treated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
pg/ml	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Staining	NULL
of	NULL
cells	NULL
with	NULL
myeloma	NULL
P3X63	NULL
antibody	NULL
was	NULL
included	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

B	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
plasmid	NULL
pAIM1.4-Luc	NULL
,	NULL
and	NULL
the	NULL
TNF-a-induced	NULL
luciferase	NULL
activity	NULL
was	NULL
analyzed	NULL
in	NULL
three	NULL
independent	NULL
clones	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
are	NULL
represented	NULL
in	NULL
light	NULL
units/10	NULL
``	NULL
cells	NULL
.	NULL

C	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
promoter	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
members	NULL
.	NULL

Five	NULL
ug	NULL
of	NULL
construct	NULL
pAIM1.4-Lue	NULL
were	NULL
cotransfected	NULL
into	NULL
K562	NULL
cells	NULL
with	NULL
5	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
pRe/CMV-p50	NULL
,	NULL
pRe/CMV-RelA	NULL
,	NULL
or	NULL
pRe/CMV-c-Rel	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
are	NULL
represented	NULL
as	NULL
fold	NULL
activation	NULL
over	NULL
the	NULL
value	NULL
obtained	NULL
with	NULL
construct	NULL
pAIM	NULL
1.4-Lue	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
empty	NULL
vector	NULL
pRe/CMV	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
that	NULL
could	NULL
be	NULL
recognized	NULL
by	NULL
the	NULL
immediate-early	NULL
growth-response	NULL
transcription	NULL
factor	NULL
Egr-1/Krox-24	NULL
,	NULL
which	NULL
has	NULL
been	NULL
described	NULL
to	NULL
be	NULL
inducible	NULL
by	NULL
PMA	NULL
(	NULL
Kramer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

TNF-a	NULL
Treatment	NULL
Induces	NULL
the	NULL
Expression	NULL
of	NULL
the	NULL
CD69	NULL
Antigen	NULL
and	NULL
the	NULL
Activity	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
Promoter-The	NULL
restricted	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
in	NULL
vivo	NULL
,	NULL
at	NULL
places	NULL
where	NULL
inflammation	NULL
occurs	NULL
(	NULL
Garcia-Monzon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Laffon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
within	NULL
the	NULL
CD69	NULL
promoter	NULL
region	NULL
led	NULL
us	NULL
to	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
TNF-	NULL
«	NULL
,	NULL
a	NULL
cytokine	NULL
that	NULL
promotes	NULL
inflammation	NULL
and	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Baeuerle	NULL
and	NULL
Henkel	NULL
,	NULL
1994	NULL
)	NULL
,	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
.	NULL

First	NULL
,	NULL
we	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
on	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
human	NULL
recombinant	NULL
TNF-a	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
TNF-a	NULL
treatment	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
CD69	NULL
expression	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
compared	NULL
with	NULL
PMA-treated	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
increase	NULL
in	NULL
CD69	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
TNF-	NULL
«	NULL
@	NULL
was	NULL
mediated	NULL
by	NULL
changes	NULL
in	NULL
the	NULL
CD69	NULL
promoter	NULL
activity	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
CD69	NULL
promoter-derived	NULL
construct	NULL
pAIM1.4-Luc	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
TNF-w-induced	NULL
promoter	NULL
activity	NULL
was	NULL
analyzed	NULL
in	NULL
three	NULL
independent	NULL
clones	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
luciferase	NULL
activity	NULL
produced	NULL
by	NULL
this	NULL
plasmid	NULL
in	NULL
unstimulated	NULL
and	NULL
transfectants	NULL
showed	NULL
that	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
augmented	NULL
4-5	NULL
times	NULL
upon	NULL
cytokine	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
result	NULL
demonstrates	NULL
that	NULL
the	NULL
CD69	NULL
promoter	NULL
contains	NULL
TNF-	NULL
«	NULL
-responsive	NULL
elements	NULL
that	NULL
are	NULL
accounting	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
for	NULL
the	NULL
TNF-a-mediated	NULL
induction	NULL
of	NULL
CD69	NULL
expression	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
cytokine	NULL
induction	NULL
of	NULL
many	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B-related	NULL
proteins	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
promoter	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
construct	NULL
pAIM1.4-Lue	NULL
and	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
c-Rel	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
p50	NULL
was	NULL
unable	NULL
to	NULL
transactivate	NULL
the	NULL
promoter	NULL
,	NULL
whereas	NULL
c-Rel	NULL
and	NULL
RelA	NULL
efficiently	NULL
induced	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
4-5-	NULL
and	NULL
12-18-fold	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
cotransfection	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
p50-	NULL
and	NULL
Rel¥A-encoding	NULL
plasmids	NULL
did	NULL
not	NULL
result	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
«	NULL
B-2	NULL
Site	NULL
Is	NULL
Responsible	NULL
for	NULL
TNF-a	NULL
Inducibility	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
Promoter-To	NULL
identify	NULL
the	NULL
cis-acting	NULL
sequences	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
promoter	NULL
involved	NULL
in	NULL
the	NULL
response	NULL
to	NULL
TNF-	NULL
«	NULL
@	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
different	NULL
CD69	NULL
promoter-derived	NULL
constructs	NULL
,	NULL
which	NULL
contained	NULL
three	NULL
,	NULL
two	NULL
,	NULL
one	NULL
,	NULL
or	NULL
none	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
Figs	NULL
.	NULL

1B	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
luciferase	NULL
activity	NULL
produced	NULL
by	NULL
the	NULL
different	NULL
plasmids	NULL
in	NULL
unstimulated	NULL
and	NULL
TNF-	NULL
@	NULL
-stimulated	NULL
cells	NULL
showed	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
located	NULL
between	NULL
positions	NULL
-480	NULL
and	NULL
-255	NULL
,	NULL
which	NULL
eliminated	NULL
the	NULL
«	NULL
B-3	NULL
site	NULL
,	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
response	NULL
to	NULL
TNF-a	NULL
,	NULL
whereas	NULL
further	NULL
removal	NULL
of	NULL
the	NULL
sequences	NULL
from	NULL
positions	NULL
-255	NULL
to	NULL
-170	NULL
,	NULL
which	NULL
deleted	NULL
the	NULL
xB-2	NULL
site	NULL
,	NULL
abolished	NULL
the	NULL
induction	NULL
by	NULL
TNF-	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
this	NULL
unresponsive	NULL
construct	NULL
(	NULL
pAIM170-Luc	NULL
)	NULL
still	NULL
conserved	NULL
the	NULL
«	NULL
B-1	NULL
site	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
response	NULL
to	NULL
TNF-a	NULL
is	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel-related	NULL
proteins	NULL
to	NULL
the	NULL
«	NULL
B-2	NULL
site	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
point	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
CD69	NULL
promoter	NULL
constructs	NULL
and	NULL
the	NULL
expression	NULL
vector	NULL
pRe/CMV-RelA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
transactivation	NULL
of	NULL
the	NULL
different	NULL
CD69	NULL
promoter	NULL
fragments	NULL
by	NULL
RelA	NULL
correlated	NULL
with	NULL
the	NULL
response	NULL
of	NULL
these	NULL
constructs	NULL
to	NULL
TNF-	NULL
«	NULL
@	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
containing	NULL
the	NULL
«	NULL
B-2	NULL
site	NULL
greatly	NULL
diminishes	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
by	NULL
RelA	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
Family	NULL
Bind	NULL
to	NULL
the	NULL
«	NULL
B-2	NULL
and	NULL
kB-1	NULL
Motifs	NULL
of	NULL
the	NULL
CD69	NULL
Gene-The	NULL
data	NULL
presented	NULL
above	NULL
indicate	NULL
that	NULL
the	NULL
TNF-	NULL
«	NULL
-induced	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
is	NULL
mainly	NULL
mediated	NULL
by	NULL
the	NULL
«	NULL
kB-2	NULL
site	NULL
.	NULL

However	NULL
,	NULL
since	NULL
the	NULL
shortest	NULL
promoter	NULL
fragment	NULL
responsive	NULL
to	NULL
TNF-a	NULL
(	NULL
pAIM255-Luc	NULL
)	NULL
contained	NULL
the	NULL
kB-2	NULL
and	NULL
«	NULL
B-1	NULL
sites	NULL
,	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
latter	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
to	NULL
the	NULL
overall	NULL
TNF-	NULL
«	NULL
response	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

To	NULL
analyze	NULL
whether	NULL
these	NULL
two	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
were	NULL
capable	NULL
of	NULL
binding	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
members	NULL
,	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
as	NULL
probes	NULL
two	NULL
double-stranded	NULL
oligonucleotides	NULL
(	NULL
CD69-	NULL
«	NULL
B-1	NULL
and	NULL
CD69-	NULL
«	NULL
B-2	NULL
)	NULL
containing	NULL
these	NULL
motifs	NULL
.	NULL

First	NULL
,	NULL
these	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
COS-7	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
expression	NULL
vectors	NULL
pRe/CMV-p50	NULL
and	NULL
pRe/CMV-RelA	NULL
.	NULL

Two	NULL
major	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
observed	NULL
with	NULL
both	NULL
oligonucleotides	NULL
when	NULL
they	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
transfected	NULL
COS-7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

These	NULL
bands	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
A	NULL
|	NULL
soo-EZESI	NULL
MEDIUM	NULL
He	NULL
TNF	NULL
fas	NULL
150-2	NULL
g	NULL
so	NULL
&	NULL
Tk	NULL
a	NULL
E	NULL
ss	NULL
100-LJ	NULL
i	NULL
&	NULL
3	NULL
S	NULL
3	NULL
_I	NULL
50	NULL
-I	NULL
o	NULL
o	NULL
oo	NULL
g	NULL
-	NULL
p	NULL
®	NULL
3	NULL
3	NULL
4	NULL
10	NULL
4	NULL
4°	NULL
§	NULL
j	NULL
0	NULL
w	NULL
I	NULL
,	NULL
<	NULL
&	NULL
ub	NULL
&	NULL
3	NULL
x	NULL
&	NULL
ar	NULL
T	NULL
o	NULL
c	NULL
un	NULL
[	NULL
st	NULL
co	NULL
co	NULL
%	NULL
O	NULL
Ean	NULL
to	NULL
€	NULL
ol	NULL
-	NULL
De	NULL
o	NULL
o	NULL
5	NULL
E0	NULL
E	NULL
o	NULL
&	NULL
-	NULL
Z	NULL
-	NULL
%	NULL
&	NULL
<	NULL
2	NULL
:	NULL
<	NULL
<	NULL
<	NULL
§	NULL
°	NULL
100	NULL
%	NULL
f	NULL
f	NULL
f	NULL
f	NULL
i	NULL
B	NULL
450	NULL
12x	NULL
E33	NULL
pRC/CMV	NULL
16x	NULL
EBBR	NULL
PRC/CMV-RelA	NULL
400	NULL
14x	NULL
16x	NULL
350-	NULL
I	NULL
I	NULL
LUCIFERASE	NULL
ACTIVITY	NULL
{	NULL
LIGHT	NULL
unit	NULL
's	NULL
x1000	NULL
)	NULL
50	NULL
--	NULL
i	NULL
pAIM624-Lue	NULL
bass	NULL
pAIM1.A-LuC	NULL
-	NULL
biking	NULL
pAIM480-Lue	NULL
pAIM255-Luc	NULL
i	NULL
pAIM170-Lue	NULL
Nota	NULL
pAIM78-Luc	NULL
pAIM3§-Luc	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
by	NULL
TNF-a	NULL
is	NULL
achieved	NULL
through	NULL
the	NULL
sequence	NULL
spanning	NULL
positions	NULL
-255	NULL
to	NULL
-170	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
NF-B-2	NULL
motif	NULL
.	NULL

A	NULL
,	NULL
CD69	NULL
promoter-based	NULL
luciferase	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
half	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TNF-a	NULL
for	NULL
16	NULL
h.	NULL
Each	NULL
transfection	NULL
was	NULL
carried	NULL
out	NULL
five	NULL
times	NULL
,	NULL
and	NULL
a	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
each	NULL
of	NULL
the	NULL
CD69	NULL
promoter-derived	NULL
constructs	NULL
were	NULL
cotransfected	NULL
into	NULL
K562	NULL
cells	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
pRe/CMV-RelA	NULL
.	NULL

Numbers	NULL
above	NULL
the	NULL
bars	NULL
indicate	NULL
-fold	NULL
transactivation	NULL
over	NULL
the	NULL
values	NULL
obtained	NULL
by	NULL
cotransfection	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
pRe/CMV	NULL
.	NULL

corresponded	NULL
to	NULL
the	NULL
homodimer	NULL
of	NULL
p50	NULL
(	NULL
KBF1	NULL
)	NULL
and	NULL
the	NULL
het-erodimer	NULL
p50/RelIA	NULL
(	NULL
NF-kB	NULL
)	NULL
and	NULL
were	NULL
not	NULL
observed	NULL
using	NULL
extracts	NULL
from	NULL
untransfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Competition	NULL
assays	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
oligonucleotide	NULL
KBF	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
of	NULL
the	NULL
H-2K	NULL
``	NULL
®	NULL
gene	NULL
,	NULL
completely	NULL
prevented	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
two	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
unrelated	NULL
oligonucleotides	NULL
AP-1	NULL
and	NULL
OCT-1	NULL
did	NULL
not	NULL
compete	NULL
the	NULL
binding	NULL
to	NULL
both	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel-related	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
21549	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
in	NULL
CD6Q-expressing	NULL
cells	NULL
,	NULL
the	NULL
two	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
untreated	NULL
K562	NULL
cells	NULL
and	NULL
from	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
TNF-	NULL
@	NULL
.	NULL

Four	NULL
inducible	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
a-d	NULL
)	NULL
were	NULL
observed	NULL
with	NULL
both	NULL
oligonucleotide	NULL
probes	NULL
when	NULL
they	NULL
were	NULL
incubated	NULL
with	NULL
extracts	NULL
from	NULL
PMA-	NULL
and	NULL
TNF-a-treated	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
observed	NULL
with	NULL
both	NULL
probes	NULL
displayed	NULL
identical	NULL
electrophoretic	NULL
mobility	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
bind	NULL
the	NULL
same	NULL
nuclear	NULL
factors	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
oligonucleotide	NULL
CD69-	NULL
«	NULL
B-1	NULL
,	NULL
which	NULL
bound	NULL
a	NULL
lesser	NULL
amount	NULL
of	NULL
nuclear	NULL
proteins	NULL
,	NULL
contained	NULL
one	NULL
mismatch	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
consensus	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
(	NULL
5'-GGGRNTYYC-3	NULL
'	NULL
)	NULL
,	NULL
whereas	NULL
oligonucleotide	NULL
CD69-	NULL
«	NULL
B-2	NULL
perfectly	NULL
matched	NULL
the	NULL
consensus	NULL
sequence	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
oligonucleotide	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
completely	NULL
abolished	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
inducible	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
the	NULL
heterologous	NULL
oligonucleotide	NULL
VP9	NULL
,	NULL
which	NULL
contained	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
from	NULL
the	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
promoter	NULL
,	NULL
efficiently	NULL
competed	NULL
the	NULL
specific	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
heterologous	NULL
competitor	NULL
that	NULL
lacked	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
members	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
NF-kB	NULL
motifs	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
promoter	NULL
,	NULL
the	NULL
binding	NULL
reactions	NULL
were	NULL
preincubated	NULL
with	NULL
antiserum	NULL
specific	NULL
to	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
p52	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
anti-p50	NULL
antiserum	NULL
induced	NULL
the	NULL
disappearance	NULL
or	NULL
reduced	NULL
the	NULL
intensity	NULL
of	NULL
complexes	NULL
b-d	NULL
.	NULL

The	NULL
anti-RelA	NULL
antiserum	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
complexes	NULL
a	NULL
and	NULL
b	NULL
,	NULL
whereas	NULL
the	NULL
anti-c-Rel	NULL
antiserum	NULL
inhibited	NULL
only	NULL
complex	NULL
c.	NULL
In	NULL
contrast	NULL
,	NULL
the	NULL
anti-p52	NULL
antiserum	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
any	NULL
of	NULL
these	NULL
complexes	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
slower	NULL
migrating	NULL
complex	NULL
(	NULL
complex	NULL
a	NULL
)	NULL
corresponds	NULL
to	NULL
a	NULL
homodimer	NULL
of	NULL
RelA	NULL
,	NULL
which	NULL
is	NULL
more	NULL
easily	NULL
detected	NULL
when	NULL
using	NULL
oligonucleotide	NULL
CD69-	NULL
«	NULL
B-2	NULL
.	NULL

Then	NULL
,	NULL
from	NULL
top	NULL
to	NULL
bottom	NULL
,	NULL
the	NULL
complexes	NULL
correspond	NULL
to	NULL
p50/ReIA	NULL
(	NULL
complex	NULL
b	NULL
)	NULL
and	NULL
p50/c-Rel	NULL
(	NULL
complex	NULL
c	NULL
)	NULL
heterodimers	NULL
and	NULL
to	NULL
a	NULL
p50	NULL
homodimer	NULL
(	NULL
complex	NULL
d	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
confirm	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
of	NULL
the	NULL
proximal	NULL
CD69	NULL
promoter	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
inducible	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

factors	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
they	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
TNF-a-mediated	NULL
induction	NULL
of	NULL
CD69	NULL
gene	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
The	NULL
transcription	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
appears	NULL
to	NULL
be	NULL
tightly	NULL
regulated	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
it	NULL
is	NULL
almost	NULL
exclusively	NULL
expressed	NULL
at	NULL
sites	NULL
were	NULL
inflammation	NULL
takes	NULL
place	NULL
,	NULL
suggesting	NULL
that	NULL
inflammatory	NULL
cytokines	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
control	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
isolation	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
CD69	NULL
gene	NULL
promoter	NULL
re-gion	NULL
.	NULL

We	NULL
have	NULL
focused	NULL
mainly	NULL
on	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
cis-acting	NULL
sequences	NULL
and	NULL
the	NULL
nuclear	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
CD69-encoding	NULL
gene	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
has	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
proximal	NULL
fragment	NULL
of	NULL
94	NULL
bp	NULL
(	NULL
nucleotides	NULL
-78	NULL
to	NULL
+16	NULL
)	NULL
that	NULL
is	NULL
sufficient	NULL
to	NULL
govern	NULL
basal	NULL
and	NULL
PMA-induced	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
proximal	NULL
promoter	NULL
domain	NULL
contains	NULL
a	NULL
canonical	NULL
TATA	NULL
box	NULL
and	NULL
a	NULL
GC-rich	NULL
sequence	NULL
that	NULL
could	NULL
be	NULL
a	NULL
target	NULL
for	NULL
Sp1	NULL
,	NULL
a	NULL
ubiquitous	NULL
and	NULL
constitutive	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
promoter	NULL
of	NULL
many	NULL
genes	NULL
,	NULL
and	NULL
Egr-1/Krox-24	NULL
,	NULL
a	NULL
zinc-finger	NULL
transcription	NULL
factor	NULL
whose	NULL
expression	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
various	NULL
agents	NULL
,	NULL
including	NULL
phorbol	NULL
esters	NULL
,	NULL
and	NULL
that	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T-	NULL
and	NULL
B-lymphocytes	NULL
(	NULL
McMahon	NULL
and	NULL
Monroe	NULL
,	NULL
1995	NULL
;	NULL
Kramer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Pérez-Castillo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
synthesis	NULL
of	NULL
CD69-encoding	NULL
mRNA	NULL
is	NULL
rapidly	NULL
induced	NULL
upon	NULL
PMA	NULL
stimulation	NULL
of	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21550	NULL
A	NULL
KB1	NULL
KB2	NULL
a	NULL
ooo	NULL
wo	NULL
Ho	NULL
t	NULL
EOT	NULL
Competitor	NULL
:	NULL
woo+	NULL
E	NULL
83	NULL
:	NULL
~	NULL
a	NULL
!	NULL
)	NULL

8	NULL
g	NULL
n	NULL
<	NULL
\pS0/ReIA	NULL
'	NULL
=u	NULL
H	NULL
'	NULL
<	NULL
1p50	NULL
,	NULL
*	NULL
HBB	NULL
a	NULL
1	NULL
1	NULL
2B	NULL
8	NULL
4	NULL
500	NULL
6	NULL
7	NULL
8	NULL
9	NULL
B	NULL
KB-2	NULL
KB-1	NULL
F	NULL
cu	NULL
Row	NULL
,	NULL
&	NULL
a	NULL
E	NULL
&	NULL
m	NULL
E	NULL
competitor	NULL
:	NULL
--	NULL
-	NULL
O	NULL
¥	NULL
>	NULL
-	NULL
--	NULL
OM	NULL
>	NULL
treatment	NULL
:	NULL
-P	NULL
T	NULL
T	NULL
T	NULL
T-	NULL
PT	NULL
T	NULL
T	NULL
T	NULL
goo	NULL
(	NULL
i	NULL
gic	NULL
wars	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
910	NULL
1112	NULL
C	NULL
TNF	NULL
TNF	NULL
4	NULL
o	NULL
40	NULL
LW	NULL
LW	NULL
&	NULL
--	NULL
:	NULL
e	NULL
W	NULL
ou	NULL
&	NULL
_	NULL
:	NULL
CC	NULL
OA	NULL
CC	NULL
wm	NULL
q	NULL
``	NULL
;	NULL
L	NULL
Ab	NULL
:	NULL
EEﬁé	NULL
’	NULL
éEEEmmom	NULL
tif	NULL
RelA	NULL
,	NULL
_	NULL
PSQ/ReIA	NULL
_	NULL
,	NULL
b	NULL
lid	NULL
PSQ/c-Rel	NULL
-	NULL
.	NULL

tout	NULL
4	NULL
,	NULL
.	NULL

,	NULL
bu	NULL
bue	NULL
|-	NULL
bath	NULL
i	NULL
0	NULL
pud	NULL
<	NULL
/	NULL
wld	NULL
P50	NULL
;	NULL
i1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
she	NULL
9	NULL
``	NULL
1o	NULL
”	NULL
11	NULL
``	NULL
1	NULL
’	NULL
2	NULL
}	NULL
KB	NULL
2	NULL
KBi	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

The	NULL
«	NULL
B-2	NULL
and	NULL
«	NULL
B-1	NULL
motifs	NULL
of	NULL
the	NULL
proximal	NULL
CD69	NULL
promoter	NULL
region	NULL
are	NULL
recognized	NULL
by	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
members	NULL
.	NULL

A	NULL
,	NULL
mobility	NULL
band	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
CD69-kB-1	NULL
(	NULL
Zanes	NULL
1-5	NULL
)	NULL
and	NULL
CD69-	NULL
«	NULL
B-2	NULL
(	NULL
Zanes	NULL
6-9	NULL
)	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
putative	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
located	NULL
at	NULL
positions	NULL
-160	NULL
and	NULL
-223	NULL
,	NULL
respectively	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
COS-7	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
and	NULL
from	NULL
COS-7	NULL
cells	NULL
transfected	NULL
with	NULL
pRe/CMV-p50	NULL
and	NULL
pRe/CMV-RelA	NULL
(	NULL
lanes	NULL
2-9	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
0.5	NULL
ng	NULL
of	NULL
each	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
50-fold	NULL
molar	NULL
excess	NULL
and	NULL
included	NULL
oligonucleotide	NULL
KBF	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
H-2K®	NULL
gene	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
and	NULL
the	NULL
unrelated	NULL
oligonucleotides	NULL
OCT-1	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
9	NULL
)	NULL
.	NULL

B	NULL
,	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
Zanes	NULL
1-6	NULL
)	NULL
and	NULL
CD69-	NULL
«	NULL
B-1	NULL
(	NULL
lanes	NULL
7-12	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
Janes	NULL
1	NULL
and	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
the	NULL
cells	NULL
(	NULL
Lépez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
additional	NULL
pre-existing	NULL
transcription	NULL
factors	NULL
should	NULL
mediate	NULL
the	NULL
PMA-induced	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
to	NULL
ensure	NULL
a	NULL
rapid	NULL
transcriptional	NULL
response	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
computer-aided	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
NF-kB	NULL
motifs	NULL
(	NULL
positions	NULL
-160	NULL
,	NULL
-223	NULL
,	NULL
and	NULL
-374	NULL
)	NULL
and	NULL
at	NULL
least	NULL
one	NULL
putative	NULL
AP-1-binding	NULL
site	NULL
(	NULL
position	NULL
-956	NULL
)	NULL
,	NULL
which	NULL
may	NULL
cooperate	NULL
with	NULL
the	NULL
proximal	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
response	NULL
to	NULL
phorbol	NULL
esters	NULL
.	NULL

We	NULL
demonstrate	NULL
herewith	NULL
that	NULL
TNF-a	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
and	NULL
that	NULL
this	NULL
induction	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
CD69	NULL
promoter	NULL
activity	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
with	NULL
CD69	NULL
promoter-derived	NULL
reporter	NULL
constructs	NULL
and	NULL
NF-	NULL
«	NULL
B-encoding	NULL
vectors	NULL
show	NULL
that	NULL
this	NULL
promoter	NULL
is	NULL
transactivated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
,	NULL
specially	NULL
by	NULL
RelA	NULL
(	NULL
formerly	NULL
p65	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TNF-o-induced	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
to	NULL
one	NULL
or	NULL
more	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
.	NULL

This	NULL
point	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
sequence	NULL
that	NULL
contains	NULL
the	NULL
«	NULL
B-2	NULL
motif	NULL
(	NULL
nucleotides	NULL
-255	NULL
to	NULL
-170	NULL
)	NULL
completely	NULL
abolishes	NULL
the	NULL
response	NULL
to	NULL
TNF-a	NULL
and	NULL
markedly	NULL
reduces	NULL
RelA-mediated	NULL
transactivation	NULL
.	NULL

Since	NULL
no	NULL
additional	NULL
elements	NULL
are	NULL
present	NULL
in	NULL
this	NULL
sequence	NULL
,	NULL
our	NULL
results	NULL
strongly	NULL
indicate	NULL
that	NULL
the	NULL
«	NULL
B-2	NULL
motif	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
TNF-	NULL
@	NULL
-induced	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
to	NULL
define	NULL
unambiguously	NULL
the	NULL
contribution	NULL
of	NULL
«	NULL
B-2	NULL
and	NULL
the	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
to	NULL
the	NULL
response	NULL
to	NULL
TNF-a	NULL
,	NULL
we	NULL
are	NULL
currently	NULL
performing	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
these	NULL
motifs	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
promoter	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
two	NULL
most	NULL
proximal	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
of	NULL
the	NULL
CD69	NULL
promoter	NULL
(	NULL
«	NULL
B-2	NULL
and	NULL
«	NULL
B-1	NULL
)	NULL
bind	NULL
four	NULL
PMA-	NULL
and	NULL
TNF-	NULL
«	NULL
-inducible	NULL
NF-	NULL
«	NULL
B/Rel-related	NULL
complexes	NULL
.	NULL

The	NULL
higher	NULL
affinity	NULL
of	NULL
these	NULL
proteins	NULL
for	NULL
the	NULL
kB-2	NULL
sequence	NULL
further	NULL
emphasizes	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
this	NULL
motif	NULL
and	NULL
may	NULL
explain	NULL
why	NULL
constructs	NULL
containing	NULL
only	NULL
the	NULL
site	NULL
are	NULL
unresponsive	NULL
to	NULL
TNF-a	NULL
.	NULL

Antisera	NULL
directed	NULL
against	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
were	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
family	NULL
members	NULL
present	NULL
in	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
detected	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif-derived	NULL
probes	NULL
.	NULL

These	NULL
experiments	NULL
revealed	NULL
that	NULL
the	NULL
DNA-binding	NULL
activities	NULL
consisted	NULL
of	NULL
a	NULL
RelA	NULL
homodimer	NULL
,	NULL
p50/RelA	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
,	NULL
and	NULL
a	NULL
p50	NULL
homodimer	NULL
.	NULL

The	NULL
most	NULL
prominent	NULL
complexes	NULL
were	NULL
composed	NULL
of	NULL
p50/ReIA	NULL
and	NULL
p50/c-Rel	NULL
het-erodimers	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
RelA	NULL
homodimer	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
B-2	NULL
motif	NULL
,	NULL
a	NULL
complex	NULL
that	NULL
is	NULL
not	NULL
easily	NULL
detected	NULL
with	NULL
the	NULL
NF-KB	NULL
sites	NULL
of	NULL
other	NULL
promoters	NULL
(	NULL
Ganchi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
sequence	NULL
of	NULL
this	NULL
motif	NULL
matches	NULL
perfectly	NULL
with	NULL
the	NULL
consensus	NULL
binding	NULL
sequence	NULL
for	NULL
RelA	NULL
,	NULL
5'-GGGRNTTTCC-3	NULL
'	NULL
(	NULL
Kunsch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
post-transcriptional	NULL
level	NULL
by	NULL
a	NULL
rapid	NULL
degradation	NULL
pathway	NULL
associated	NULL
with	NULL
AU-rich	NULL
sequence	NULL
motifs	NULL
(	NULL
Santis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

This	NULL
mechanism	NULL
of	NULL
regulation	NULL
has	NULL
7	NULL
)	NULL
and	NULL
from	NULL
K562	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
P	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
lanes	NULL
3-6	NULL
and	NULL
9-12	NULL
)	NULL
.	NULL

Competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
50-fold	NULL
molar	NULL
excess	NULL
and	NULL
included	NULL
the	NULL
specific	NULL
competitors	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
17	NULL
)	NULL
,	NULL
oligonucleotide	NULL
VP9	NULL
(	NULL
which	NULL
contains	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
from	NULL
the	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
promoter	NULL
)	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
,	NULL
and	NULL
the	NULL
unrelated	NULL
oligonucleotide	NULL
OCT-1	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Specific	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
a-d	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

C	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
anes	NULL
1	NULL
and	NULL
7	NULL
)	NULL
or	NULL
from	NULL
K562	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
lanes	NULL
2-6	NULL
and	NULL
8-12	NULL
)	NULL
were	NULL
preincubated	NULL
either	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
PRE	NULL
;	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
with	NULL
antiserum	NULL
specific	NULL
to	NULL
p50	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
10	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
11	NULL
)	NULL
,	NULL
or	NULL
p52	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
CD69-kB-2	NULL
(	NULL
Zanes	NULL
1-6	NULL
)	NULL
or	NULL
CD69-B-1	NULL
(	NULL
lanes	NULL
7-12	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
obtained	NULL
with	NULL
probe	NULL
CD69-kB-1	NULL
were	NULL
exposed	NULL
three	NULL
times	NULL
longer	NULL
than	NULL
those	NULL
obtained	NULL
with	NULL
CD69-kB-2	NULL
to	NULL
get	NULL
a	NULL
similar	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
CD69	NULL
Gene	NULL
been	NULL
found	NULL
in	NULL
many	NULL
genes	NULL
involved	NULL
in	NULL
inflammatory	NULL
and	NULL
activation	NULL
responses	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
genes	NULL
code	NULL
for	NULL
cytokines	NULL
and	NULL
oncoproteins	NULL
,	NULL
which	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
initial	NULL
events	NULL
leading	NULL
to	NULL
activation	NULL
and	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
appears	NULL
to	NULL
be	NULL
highly	NULL
regulated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
of	NULL
their	NULL
promoters	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Baeuerle	NULL
and	NULL
Henkel	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
findings	NULL
,	NULL
which	NULL
highlight	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
of	NULL
the	NULL
CD69	NULL
gene	NULL
,	NULL
further	NULL
support	NULL
the	NULL
idea	NULL
regarding	NULL
a	NULL
general	NULL
mechanism	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
expression	NULL
of	NULL
activation-associated	NULL
genes	NULL
during	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CD69-encoding	NULL
mRNA	NULL
can	NULL
be	NULL
easily	NULL
induced	NULL
in	NULL
most	NULL
leukocytes	NULL
by	NULL
treatment	NULL
``	NULL
in	NULL
vitro	NULL
``	NULL
with	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
stimuli	NULL
such	NULL
as	NULL
PMA	NULL
or	NULL
anti-CD3/T	NULL
cell	NULL
receptor	NULL
mAb	NULL
(	NULL
Lépez-Cabrera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Ziegler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
on	NULL
activated	NULL
T-lymphocytes	NULL
from	NULL
cell	NULL
infiltrates	NULL
of	NULL
various	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
such	NULL
as	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
chronic	NULL
viral	NULL
hepatitis	NULL
has	NULL
been	NULL
documented	NULL
(	NULL
Garcia-Monzon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Laffon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
known	NULL
that	NULL
TNF-a	NULL
is	NULL
an	NULL
important	NULL
inflammatory	NULL
mediator	NULL
that	NULL
is	NULL
actively	NULL
secreted	NULL
by	NULL
several	NULL
cell	NULL
types	NULL
at	NULL
inflammatory	NULL
sites	NULL
(	NULL
Gonzglez-Amaro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Vassalli	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
pro-inflammatory	NULL
cytokine	NULL
TNF-a	NULL
may	NULL
play	NULL
a	NULL
key	NULL
role	NULL
``	NULL
in	NULL
vivo	NULL
``	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
by	NULL
inflammatory	NULL
cells	NULL
.	NULL

Interestingly	NULL
enough	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
that	NULL
CD69	NULL
antigen	NULL
is	NULL
in	NULL
turn	NULL
capable	NULL
of	NULL
generating	NULL
signals	NULL
that	NULL
induce	NULL
the	NULL
synthesis	NULL
of	NULL
TNF-	NULL
«	NULL
by	NULL
lymphoid	NULL
cells	NULL
(	NULL
Santis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
feasible	NULL
that	NULL
,	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
,	NULL
a	NULL
positive	NULL
feed-back	NULL
loop	NULL
is	NULL
established	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
and	NULL
the	NULL
production	NULL
of	NULL
TNF-a	NULL
.	NULL

The	NULL
putative	NULL
ligand	NULL
of	NULL
CD69	NULL
should	NULL
be	NULL
clearly	NULL
involved	NULL
in	NULL
this	NULL
condition	NULL
.	NULL

The	NULL
above	NULL
phenomenon	NULL
could	NULL
have	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
perpetuation	NULL
of	NULL
several	NULL
inflammatory	NULL
diseases	NULL
and	NULL
could	NULL
be	NULL
related	NULL
to	NULL
the	NULL
resistance	NULL
of	NULL
some	NULL
patients	NULL
with	NULL
these	NULL
conditions	NULL
toward	NULL
the	NULL
current	NULL
anti-inflammatory	NULL
therapy	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Drs	NULL
.	NULL

J.	NULL
M.	NULL
Redondo	NULL
and	NULL
R.	NULL
Amaro	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
acknowledge	NULL
Dr.	NULL
M.	NULL
A.	NULL
Vega	NULL
for	NULL
help	NULL
in	NULL
DNA	NULL
sequence	NULL
computer	NULL
analysis	NULL
and	NULL
Dr.	NULL
S.	NULL
Nordeen	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
plasmid	NULL
pXP2	NULL
.	NULL

REFERENCES	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
63-80	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
141-179	NULL
Cebrign	NULL
,	NULL
M.	NULL
,	NULL
Yagiie	NULL
,	NULL
E.	NULL
,	NULL
Rincon	NULL
,	NULL
M.	NULL
,	NULL
Lépez-Botet	NULL
,	NULL
M.	NULL
,	NULL
de	NULL
Landézuri	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168	NULL
,	NULL
1621-1637	NULL
Drickamer	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Struct	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
393-400	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

21551	NULL
13	NULL
,	NULL
7826-7835	NULL
Garcfa-Monzén	NULL
,	NULL
C.	NULL
,	NULL
Morenc-Otero	NULL
,	NULL
R.	NULL
,	NULL
Pajares	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Garcia-Sanchez	NULL
,	NULL
A.	NULL
,	NULL
Lopez-Botet	NULL
,	NULL
M.	NULL
,	NULL
de	NULL
M.	NULL
O.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Gastroenterology	NULL
98	NULL
,	NULL
1029-1035	NULL
Ghosh	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16	NULL
,	NULL
445-447	NULL
Gonzglez-Amaro	NULL
,	NULL
R.	NULL
,	NULL
Garcia-Monzon	NULL
,	NULL
C.	NULL
,	NULL
Garcfa-Buey	NULL
,	NULL
L.	NULL
,	NULL
Moreno-Otero	NULL
,	NULL
R.	NULL
,	NULL
Alonso	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Yagtie	NULL
,	NULL
E.	NULL
,	NULL
Pivel	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Lépez-Cabrera	NULL
,	NULL
M.	NULL
,	NULL
Ferngndez-Ruiz	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
841-848	NULL
Hamann	NULL
,	NULL
J.	NULL
,	NULL
Fiebig	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Strauss	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
4920-4927	NULL
Hara	NULL
,	NULL
T.	NULL
,	NULL
Jung	NULL
,	NULL
L.	NULL
K.	NULL
L.	NULL
,	NULL
Bjorndahl	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164	NULL
,	NULL
1988-2005	NULL
Hartnell	NULL
,	NULL
A.	NULL
,	NULL
Robinson	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Kay	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Wardlaw	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunology	NULL
80	NULL
,	NULL
281-286	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
Krimer	NULL
,	NULL
B.	NULL
,	NULL
Meichle	NULL
,	NULL
A.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Charnay	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Krénke	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1219	NULL
,	NULL
418-421	NULL
Kunsch	NULL
,	NULL
C.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4412-4421	NULL
Laffén	NULL
,	NULL
A.	NULL
,	NULL
Garcia-Vicufia	NULL
,	NULL
R.	NULL
,	NULL
Humbrifa	NULL
,	NULL
A.	NULL
,	NULL
Postigo	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Corbi	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
de	NULL
Landgzuri	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
and	NULL
S	NULL
&	NULL
nchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
546-552	NULL
Lanier	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Buck	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Rhodes	NULL
,	NULL
L.	NULL
,	NULL
Ding	NULL
,	NULL
A.	NULL
,	NULL
Evans	NULL
,	NULL
E.	NULL
,	NULL
Barney	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Phillips	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1572-1585	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Schmidt-Ullrich	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
5043-5049	NULL
Lépez-Cabrera	NULL
,	NULL
M.	NULL
,	NULL
Santis	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Ferngndez-Ruiz	NULL
,	NULL
E.	NULL
,	NULL
Blacher	NULL
,	NULL
R.	NULL
,	NULL
Esch	NULL
,	NULL
F.	NULL
,	NULL
Sanchez-Mateos	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
537-547	NULL
McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Monroe	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
417-422	NULL
Moretta	NULL
,	NULL
A.	NULL
,	NULL
Poggi	NULL
,	NULL
A.	NULL
,	NULL
Pende	NULL
,	NULL
D.	NULL
,	NULL
Tripodi	NULL
,	NULL
G.	NULL
,	NULL
Orengo	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Pella	NULL
,	NULL
N.	NULL
,	NULL
Augugliaro	NULL
,	NULL
R.	NULL
,	NULL
Bottino	NULL
,	NULL
C.	NULL
,	NULL
Ciccone	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Moretta	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1398-1398	NULL
Nakamura	NULL
,	NULL
S.	NULL
,	NULL
Sung	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bjorndahl	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169	NULL
,	NULL
677-689	NULL
Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
BioTechniques	NULL
6	NULL
,	NULL
454-457	NULL
Nueda	NULL
,	NULL
A.	NULL
,	NULL
Lépez-Cabrera	NULL
,	NULL
M.	NULL
,	NULL
Vara	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Corbi	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
19305-19311	NULL
Pérez-Castillo	NULL
,	NULL
A.	NULL
,	NULL
Pipaon	NULL
,	NULL
C.	NULL
,	NULL
Garcia	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Alemany	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
19445-19450	NULL
Sanchez-Mateos	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21	NULL
,	NULL
28317-2325	NULL
Sanchez-Mateos	NULL
,	NULL
P.	NULL
,	NULL
Cebrign	NULL
,	NULL
M.	NULL
,	NULL
Acevedo	NULL
,	NULL
A.	NULL
,	NULL
Lépez-Botet	NULL
,	NULL
M.	NULL
,	NULL
de	NULL
Land	NULL
&	NULL
zuri	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
and	NULL
S	NULL
&	NULL
nchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Immunology	NULL
68	NULL
,	NULL
72-79	NULL
Santis	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Campanero	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Alonso	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Tugores	NULL
,	NULL
A.	NULL
,	NULL
Alonso	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Yagiie	NULL
,	NULL
E.	NULL
,	NULL
Pivel	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22	NULL
,	NULL
1253-1259	NULL
Santis	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Lépez-Cabrera	NULL
,	NULL
M.	NULL
,	NULL
Hamann	NULL
,	NULL
J.	NULL
,	NULL
Strauss	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S	NULL
&	NULL
nchez-Madrid	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
,	NULL
1692-1697	NULL
Santis	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Lépez-Cabrera	NULL
,	NULL
M.	NULL
,	NULL
S	NULL
&	NULL
nchez-Madrid	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Proudfoot	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Testi	NULL
,	NULL
R.	NULL
,	NULL
Phillips	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Lanier	NULL
,	NULL
L.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1123-1128	NULL
Testi	NULL
,	NULL
R.	NULL
,	NULL
Pulcinelli	NULL
,	NULL
F.	NULL
,	NULL
Frati	NULL
,	NULL
L.	NULL
,	NULL
Gazzaniga	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
and	NULL
Santoni	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
,	NULL
701-707	NULL
Tugores	NULL
,	NULL
A.	NULL
,	NULL
Alonso	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S	NULL
&	NULL
nchez-Madrid	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
de	NULL
Land	NULL
&	NULL
zuri	NULL
,	NULL
M.	NULL
O	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
2300-2306	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
411-452	NULL
Yano	NULL
,	NULL
O.	NULL
,	NULL
Kanellopoulos	NULL
,	NULL
J.	NULL
,	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Israél	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kourilsky	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3317-3324	NULL
Yokoyama	NULL
,	NULL
W.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5	NULL
,	NULL
67-78	NULL
Ziegler	NULL
,	NULL
8	NULL
.	NULL

F.	NULL
,	NULL
Ramsdell	NULL
,	NULL
F.	NULL
,	NULL
Hjerrild	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Armitage	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Hennen	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Farrah	NULL
,	NULL
T.	NULL
,	NULL
Fanslow	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Shevach	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Alderson	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
1643-1648	NULL
Ziegler	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Levin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Johnson	NULL
,	NULL
L.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Baker	NULL
,	NULL
E.	NULL
,	NULL
Sutherland	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Feldhaus	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Ramsdell	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
1228-1236	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
Gene	NULL
Encoding	NULL
the	NULL
Human	NULL
C-type	NULL
Lectin	NULL
Leukocyte	NULL
Receptor	NULL
AIM/CD69	NULL
and	NULL
Functional	NULL
Characterization	NULL
of	NULL
Its	NULL
Tumor	NULL
Necrosis	NULL
Factor-	NULL
(	NULL
-responsive	NULL
Elements	NULL
Manuel	NULL
Lopez-Cabrera	NULL
,	NULL
Eduardo	NULL
Mufioz	NULL
,	NULL
M.	NULL
Valle	NULL
Blazquez	NULL
,	NULL
Maria	NULL
A.	NULL
Ursa	NULL
,	NULL
Ana	NULL
G.	NULL
Santis	NULL
and	NULL
Francisco	NULL
Sanchez-Madrid	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:21545-21551.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.37.21545	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/37/21545	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
37	NULL
references	NULL
,	NULL
17	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

